Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online August 6, 2004.
Copyright & Usage
THE JOURNAL OF NUCLEAR MEDICINE
Author Information
- Benoit Pirotte, MD1,
- Serge Goldman, MD, PhD2,
- Nicolas Massager, MD1,
- Philippe David, MD3,
- David Wikler, MS1,
- Arlette Vandesteene, MD, PhD4,
- Isabelle Salmon, MD, PhD5,
- Jacques Brotchi, MD, PhD1 and
- Marc Levivier, MD, PhD1
- 1Department of Neurosurgery, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium
- 2PET/Biomedical Cyclotron Unit, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium
- 3Department of Neuroradiology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium
- 4Department of Anesthesiology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium
- 5Department of Neuropathology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Amino Acid PET in Neurooncology
- Amino Acid PET in Neurooncology
- Extent and Instability of Trimethylation of Histone H3 Lysine Increases With Degree of Malignancy and Methionine Addiction
- Metabolic Phenotypes, Dependencies, and Adaptation in Lung Cancer
- The linkage of methionine addiction, overmethylation of histone H3 lysines and malignancy demonstrated when cancer cells revert to methionine-independence
- Chronic Treatment of an Advanced Prostate-cancer Patient With Oral Methioninase Resulted in Long-term Stabilization of Rapidly Rising PSA Levels
- Lowering and Stabilizing PSA Levels in Advanced-prostate Cancer Patients With Oral Methioninase
- Histone H3K4me3 and H3K9me3 are super over-methylated in soft tissue sarcoma compared to normal muscle in patient-derived xenograft (PDX) mouse models: an indicator of cancer methionine addiction
- Differentiation between Treatment-Induced Necrosis and Recurrent Tumors in Patients with Metastatic Brain Tumors: Comparison among 11C-Methionine-PET, FDG-PET, MR Permeability Imaging, and MRI-ADC--Preliminary Results
- Molecular Imaging to Plan Radiotherapy and Evaluate Its Efficacy
- Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome
- Clinical Impact of Amino Acid PET in Gliomas
- Correlation of 18F-FLT Uptake with Tumor Grade and Ki-67 Immunohistochemistry in Patients with Newly Diagnosed and Recurrent Gliomas
- Clinical applications of imaging biomarkers. Part 2. The neurosurgeon's perspective
- Multimodality Assessment of Brain Tumors and Tumor Recurrence
- Voxel-Based Analysis of Dual-Time-Point 18F-FDG PET Images for Brain Tumor Identification and Delineation
- Evaluation of 18F-FDG PET and MRI Associations in Pediatric Diffuse Intrinsic Brain Stem Glioma: A Report from the Pediatric Brain Tumor Consortium
- Quantitative, Preclinical PET of Translocator Protein Expression in Glioma Using 18F-N-Fluoroacetyl-N-(2,5-Dimethoxybenzyl)-2-Phenoxyaniline
- 1-11C-Acetate Versus 18F-FDG PET in Detection of Meningioma and Monitoring the Effect of {gamma}-Knife Radiosurgery
- Evaluation of Focal Cortical Dysplasia and Mixed Neuronal and Glial Tumors in Pediatric Epilepsy Patients Using 18F-FDG and 11C-Methionine PET
- Tumor Cell Metabolism Imaging
- Evaluation of Primary Brain Tumors Using 11C-Methionine PET with Reference to a Normal Methionine Uptake Map
- Clinical Applications of PET in Brain Tumors